|
Document and Entity Information
|
12 Months Ended |
|---|---|
|
Dec. 31, 2013
|
|
| Document And Entity Information [Abstract] | |
| Document Type | POS AM |
| Amendment Flag | true |
| AmendmentDescription | This Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-191238) (the “Registration Statement”) of Intra-Cellular Therapies, Inc. (the “Company”) is being filed pursuant to the undertakings in Item 17 of the Registration Statement to update and supplement the information contained in the Registration Statement, as originally declared effective by the Securities and Exchange Commission (the “SEC”) on December 18, 2013, to (i) include the information contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 that was filed with the SEC on March 25, 2014 and (ii) to update certain other information in the Registration Statement. |
| Document Period End Date | Dec. 31, 2013 |
| Entity Registrant Name | Intra-Cellular Therapies, Inc. |
| Entity Central Index Key | 0001567514 |
| Entity Filer Category | Smaller Reporting Company |